TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic. April 9, 2010
TCL Archive In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist November 6, 1981
TCL Archive President’s FY 1988 Budget Request For NCI: $1.87 Billion, But It Really Isn’t What It Seems To Be January 9, 1987
